GREENSBORO, N.C. – Oct, 18, 2004 – Brent Geiberger and Tom Lehman shared last week’s Crestor (rosuvastatin calcium) Charity Challenge.

The Crestor Charity Challenge is a season-long weekly competition that recognizes the tournament leader entering the final round at most PGA Tour events throughout the year. Through this first-of-its kind program, AstraZeneca and its Crestor product will donate approximately $3 million a year to designated health care and PGA Tour charities. At each of the selected tournaments, a $100,000 contribution will be made.

For the performances of Geiberger and Lehman, AstraZeneca, on behalf of its Crestor product and the Chrysler Classic of Greensboro, will donate $50,000 to Brenner Children’s Hospital, and $25,000 to the health-care charity of both Geiberger and Lehman.

Lehman, fresh off a T2 finish at last week’s Michelin Championship at Las Vegas, has posted three straight rounds in the 60s (69-66-69). Geiberger currently stands at No. 144 on the PGA TOUR money list and hopes to secure his PGA Tour card for 2005 with a strong finish this week.

“We are delighted that Crestor has chosen Brenner Children’s Hospital as the recipient of the Charity Challenge,” said Jon S. Abramson, M.D. physician-in-chief, of Brenner Children’s Hospital. “This money will go to fund research and pay for needed programs at the children’s hospital.”

Wake Forest University Baptist Medical Center is an academic health system comprised of North Carolina Baptist Hospital, Wake Forest University Health Sciences and Brenner Children’s Hospital. The system comprises 1,282 acute care, rehabilitation, psychiatry and long-term care beds. Brenner Children’s was named one of the top 30 best children’s hospitals in the nation by Child magazine.

The Crestor Charity Challenge is the centerpiece of a multi-year Tour partnership with AstraZeneca (NYSE:AZN) on behalf of its cholesterol-lowering medication, Crestor.

"Giving back is at the heart of the PGA Tour and AstraZeneca is pleased to be able to support this by offering health education and recognizing local communities through the Crestor Charity Challenge," said Tony Zook, senior vice president, commercial operations, AstraZeneca U.S. "The Crestor Charity Challenge will not only add an exciting new twist to the PGA Tour, it will also help the Tour reach its milestone of $1 billion in charitable donations within the next few years."

Crestor Charity Challenge winners will be recognized during the network or cable telecast of each tournament. In addition, AstraZeneca and Crestor will sponsor the PGA TOUR year-end charity special, which is scheduled to air December 19 on ABC.

The PGA Tour partnership also includes the Crestor Charity Challenge Pavilion, an on-site component at select tournaments featuring interactive exhibits designed to provide health and cholesterol awareness, educational activities, health screenings/assessments, and golf tips by teaching pros for fans.

Fans can log on to www.crestor.pgatour.com to take part in weekly contests, read about past Crestor Charity Challenge winners, and learn more about Crestor. Crestor also will be the official sponsor of Tour Fantasy Golf at pgatour.com/fantasy.